Serum Institute applies for trials of another COVID-19 vaccine

Updated : January 30, 2021 04:32 PM IST

The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca.

Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said his company has applied to start the trials of another COVID-19 vaccine and that it hopes to launch it by June 2021.

The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca. The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive.

In a tweet, Poonawalla said, "Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!"

The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.

Published : January 30, 2021 04:32 PM IST

Serum Institute applies for trials of another COVID-19 vaccine

You May Also Like

Private hospitals can buy COVID-19 vaccines directly from May 1

COVID vaccination: Private vaccination centres to procure directly from manufacturers starting May 1

LIC collects highest ever new premiums worth Rs 1.84 lakh crore in FY21; claims at Rs 1.34 lakh crore

Trending on CNBC-TV18

recommended for you